Metabolic syndrome and risk of age-related macular degeneration

Retina

Volumn 35, Issue 3, 2015, Pages 459-466

  Ghaem Maralani, Haleh ^a,b   Tai, Bee Choo ^a,c   Wong, Tien Y ^c,d,e   Tai, E Shyong ^f   Li, Jialiang ^a   Wang, Jie Jin ^g   Mitchell, Paul ^g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

^f Dept Medicine Endocrinol Diabet   (Singapore)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

age related macular degeneration; Blue Mountains Eye Study; metabolic syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGE RELATED MACULAR DEGENERATION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DISEASE COURSE; ENDOCRINE FUNCTION TEST; EYE COLOR; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERLIPIDEMIA; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PREDICTIVE VALUE; RETINA IMAGE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; AGED, 80 AND OVER; AUSTRALIA; DYSLIPIDEMIAS; EPIDEMIOLOGY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MACULAR DEGENERATION; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

AGED; AGED, 80 AND OVER; AUSTRALIA; DYSLIPIDEMIAS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; HYPERTENSION; MACULAR DEGENERATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 84924289827     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000338     Document Type: Article

References (40)

1. McCarty CA, Dowrick A, Cameron J, et al. Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study. BMC Ophthalmol 2008;8:25.
2. Shankar A, Mitchell P, Rochtchina E, et al. Association between circulating white blood cell count and long-term incidence of age related macular degeneration. The Blue Mountains Eye Study. Am J Epidemiol 2007;165:375-382.
3. Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol 2000;118: 47-51.
4. Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012;379:1728-1738.
5. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
6. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Oph-thalmol 2000;130:658-663.
7. Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 2010;10:31.
8. Peeters A, Magliano DJ, Stevens J, et al. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 2008;126: 1554-1560.
9. Klein R. Epidemiology of age-related macular degeneration. In: Penfold PL, Provis JM, eds. Macular Degeneration: Science and Medicine in Practice. New York, NY: Springer-Verlag; 2005:79-121.
10. Klein R, Deng Y, Klein BE, et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol 2007;143:473-483.
11. Vine AK, Stader J, Branham K, et al. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 2005;112:2076-2080.
12. Delcourt C, Michel F, Colvez A, et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 2001;8: 237-249.
13. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007; 3699:425-435.
14. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related mac-ulopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583-587.
15. Tan JSL, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration. The Blue Mountains Eye Study. Ophthalmology 2007;114:1143-1150.
16. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111:1280-1287.
17. Klein R, Klein BE, Jeensen SC. The relationship of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy. The Beaver Dam Eye study. Ophthalmology 1997;104:1804-1812
18. Klein R, Klein BE, Moss SE. Diabetes, hyperglycemia, and age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:1527-1534.
19. Mitchell P, Wang JJ. Diabetes, fasting blood glucose and age-related maculopathy. The Blue Mountains Eye Study. Aust N Z J Ophthalmol 1999;27:197-199.
20. Leske MC, Wu SY, Hennis A, et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 2006;113:29-35.
21. Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study. AREDS report No 19. Ophthalmology 2005;112:533-539.
22. Chiang PP, Lamoureux EL, Zheng Y, et al. Frequency and risk factors of non-retinopathy ocular conditions in people with diabetes: the Singapore Malay Eye Study. Diabet Med 2013; 30:e32-e40.
23. Zimmet P, Magliano D, Matsuzawa Y, et al. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005;12:295-300.
24. Mitchell P, Smith W, Wang JJ, et al. Diabetes in an older Australian population. Diabetes Res Clin Pract 1998;41:177-184.
25. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-1992.
26. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. Med J Aust 2007;186:131-135.
27. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: WHO; 1999.
28. Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology 1998;105:1359-1363.
29. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 1995;102:1450-1460.
30. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98:1128-1134.
31. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995; 39:367-374.
32. Agresti A. Categorical Data Analysis. 3rd ed. Hoboken, New Jersey: John Wiley & Sons; 2012:429-527.
33. Brown H, Prescott R. Applied Mixed Models in Medicine. 2nd ed. United Kingdom: John Wiley and Sons; 2006:22-30; 215-225.
34. Capoulade R, Clavel MA, Dumesnil JG, et al. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol 2012;60:216-223.
35. Lin HF, Liu CK, Liao YC, et al. The risk of the metabolic syndrome on carotid thickness and stiffness: sex and age specific effects. Atherosclerosis 2010;210:155-159.
36. Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol 2001;8:251-262.
37. Seddon JM, Gensler G, Milton RC, et al. Association between C-reactive protein and age-related macular degeneration. JAMA 2004;291:704-710.
38. Hidayat AA, Fine BS. Diabetic choroidopathy light and electron microscopic observations of seven cases. Ophthalmology 1985;92:512-522.
39. Fryczkowski AW, Sata SE, Hodes BL. Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann Ophthalmol 1988;20:299-305.
40. Li B, Lingsma HF, Steyerberg EW, Lesaffre E. Logistic random effects regression models: a comparison of statistical packages for binary and ordinal outcomes. BMC Med Res Methodol 2011;11:77.